Newsroom
Zhifei Biological Jumped to AA in MSCI ESG Rating...
Zhifei Biological Jumped to AA in MSCI ESG Rating
2024-10-11
Recently, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "the Company", "Company", or "Zhifei Biological") recei...
see details 》
Zhifei Attends 2023 World Lung Health Conference and Visits World Heal...
Zhifei Attends 2023 World Lung Health Conference and Visits World Health Organization
2023-12-27
From November 15th to 18th, the Union World Conference on Lung Health, the most prestigious academic conference in the field of global tuber...
Zhifei and GSK reached strategic cooperation, adding a new blockbuster...
Zhifei and GSK reached strategic cooperation, adding a new blockbuster product
2023-10-12
On October 8, 2023, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "Zhifei") and GlaxoSmithKline (GSK Biologica...
GLAD NEWS - Zhifei is Named China 500 by Fortune Magazine2022-07-14
Recently, The Fortune Plus APP released the Fortune China 500 List for 2022, and Zhifei successfully made the list, ranking 391st. In addit...
Six Months Efficacy and Safety Results of Zifivax® Published in New England Journal of Medicine2022-05-05
On May 4, 2022, the team of Dr. George Fu Gao, Academician from Institute of Microbiology, Chinese Academy of Sciences (IMCAS) officially pu...
Zhifei Lvzhu and Intravacc Reach Collaboration on Developing a Novel Pertussis Vaccine2022-04-30
Beijing, China, April 29, 2022 - Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd. (“Zhifei Lvzhu”), a wholly owned subsidiary of...
Recombinant COVID-19 Vaccine (CHO Cell) Included in List of COVID-19 Vaccines for Exportation2022-04-21
Recently, Ministry of Commerce, Ministry of Industry and Information Technology, National Health Commission and the National Medical Product...
China’s First Recombinant Protein Subunit COVID-19 Vaccine Received Conditional Marketing Approval2022-04-20
On March 1, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) developed by Zhifei Longcom has received Conditional Marketing Authorization (...